---
title: "Roth MKM Sticks to Its Buy Rating for Coya Therapeutics, Inc. (COYA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296711581.md"
description: "Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on Coya Therapeutics (COYA) with a $12.00 price target. This follows BTIG's August 11 report, which also maintained a Buy rating but set a higher target of $16.00. The coverage highlights the healthcare sector focus of these analysts."
datetime: "2026-08-23T22:35:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296711581.md)
  - [en](https://longbridge.com/en/news/296711581.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296711581.md)
generator: "portal-rs"
---

# Roth MKM Sticks to Its Buy Rating for Coya Therapeutics, Inc. (COYA)

Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on Coya Therapeutics, Inc. today and set a price target of $12.00.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Pachaiyappan is an analyst with an average return of -2.0% and a 46.95% success rate. Pachaiyappan covers the Healthcare sector, focusing on stocks such as PolyPid, CervoMed, and ProMIS Neurosciences.

In a report released on August 11, BTIG also maintained a Buy rating on the stock with a $16.00 price target.

### Related Stocks

- [COYA.US](https://longbridge.com/en/quote/COYA.US.md)
- [PYPD.US](https://longbridge.com/en/quote/PYPD.US.md)
- [CRVO.US](https://longbridge.com/en/quote/CRVO.US.md)
- [PMN.US](https://longbridge.com/en/quote/PMN.US.md)

## Related News & Research

- [Roth MKM Reaffirms Their Buy Rating on Coya Therapeutics, Inc. (COYA)](https://longbridge.com/en/news/291760677.md)
- [Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street](https://longbridge.com/en/news/286280716.md)
- [Repligen CEO, CFO to join Wells Fargo Healthcare Conference analyst discussion](https://longbridge.com/en/news/297037160.md)
- [Ausdal Financial Partners Inc. Sells 3,115 Shares of UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/297279623.md)
- [232,697 Shares in Bristol Myers Squibb Company $BMY Acquired by Beacon Pointe Advisors LLC](https://longbridge.com/en/news/297394340.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**